Table 4.
Univariate and Multivariate Regression Analysis for Different Indices Predicting CAD
| Factor | Normal N (%) (n=21) |
Abnormal N (%) (n= 69) |
Crude OR (95% CI) |
P-value | Adjusted ORa (95% CI) | P-value |
|---|---|---|---|---|---|---|
| BMI | ||||||
|
06 (27.3%) | 06 (08.6%) | Ref | Ref | ||
|
64 (91.4%) | 16 (72.7%) | 4.00 (1.14–14.1) | 0.031** | 5.48 (1.35–22.2) | 0.017** |
| WC | ||||||
|
16 (72.7%) | 23 (32.9%) | Ref | Ref | ||
|
06 (27.3%) | 47 (67.1%) | 5.45 (1.88–15.8) | 0.002** | 6.74 (2.16–21.1) | 0.001** |
| HC | ||||||
|
15 (68.2%) | 29 (41.4%) | Ref | Ref | ||
|
07 (31.8%) | 41 (58.6%) | 3.03 (1.09–8.36) | 0.032** | 1.01 (0.19–5.27) | 0.987 |
| WHR | ||||||
|
09 (40.9%) | 35 (52.2%) | Ref | Ref | ||
|
13 (59.1%) | 32 (47.8%) | 0.63 (0.24–1.68) | 0.358 | 0.62 (0.23–1.69) | 0.354 |
| WHtR | ||||||
|
13 (59.1%) | 27 (40.3%) | Ref | Ref | ||
|
09 (40.9%) | 40 (59.7%) | 2.14 (0.80–5.70) | 0.128 | 2.39 (0.86–6.65) | 0.095 |
| SCFT | ||||||
|
14 (63.6%) | 28 (40.0%) | Ref | Ref | ||
|
08 (36.4%) | 42 (60.0%) | 2.62 (0.97–7.08) | 0.056 | 1.29 (0.39–4.25) | 0.679 |
| PPFT | ||||||
|
14 (63.6%) | 27 (38.6%) | Ref | Ref | ||
|
08 (36.4%) | 43 (61.4%) | 2.79 (1.03–7.52) | 0.043** | 1.84 (0.56–6.05) | 0.313 |
| PRPFT | ||||||
|
19 (86.4%) | 29 (41.4%) | Ref | Ref | ||
|
03 (13.6%) | 41 (58.6%) | 8.9 (2.4–33.1) | 0.001** | 12.3 (2.9–51.6) | 0.001** |
| VFT | ||||||
|
13 (59.1%) | 16 (22.9%) | Ref | Ref | ||
|
09 (40.9%) | 54 (77.1%) | 4.9 (1.8–13.5) | 0.002** | 5.7 (1.9–16.9) | 0.002** |
| VFT/SCFT | ||||||
|
10 (45.5%) | 24 (34.3%) | Ref | Ref | ||
|
12 (54.5%) | 46 (65.7%) | 1.59 (0.60–4.23) | 0.346 | 2.50 (0.78–7.97) | 0.121 |
| VAT | ||||||
|
15 (68.2%) | 16 (22.9%) | Ref | Ref | ||
|
54 (77.1%) | 07 (31.8%) | 7.2 (2.5–20.8) | <0.001** | 10.7 (3.0–37.3) | <0.001** |
| AFI | ||||||
|
13 (59.1%) | 57 (81.4%) | Ref | Ref | ||
|
09 (40.9%) | 13 (18.6%) | 0.33 (0.12–0.93) | 0.037** | 0.30 (0.10–0.89) | 0.030** |
Notes: aAdjusted for traditional risk factors (age, sex, smoking, diabetes mellitus, hypertension and hyperlipidemia). **Significant at P < 0.05 level (2-tailed).
Abbreviations: BMI, body mass index; WC, waist circumference, HC, hip circumference; WHR, waist to hip ratio; WHtR, waist to height ratio; PRPFT, posterior right perinephric fat thickness; SCFT, subcutaneous fat thickness; PPFT, preperitoneal fat thickness; VFT, visceral fat thickness; VFT/SCFT, visceral fat thickness over subcutaneous fat thickness; VAT, visceral adipose tissue volume; AFI, Abdominal wall fat index.